...
首页> 外文期刊>Hepatology research: the official journal of the Japan Society of Hepatology >Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria
【24h】

Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria

机译:日本肝病康迟病毒学协会(第1版):创建康迟腺尼亚评估标准的工作组的建议

获取原文
获取原文并翻译 | 示例
           

摘要

Sarcopenia is defined by muscle loss and muscle dysfunction. Sarcopenia is classified into primary and secondary types, based on the cause. Primary sarcopenia is mainly aging-related sarcopenia, whereas secondary sarcopenia is the reduced muscle mass and strength that accompanies an underlying disease. Given the essential role of the liver in metabolism, secondary sarcopenia due to nutritional disorders or other factors can frequently occur in liver disease. In 2015, the Japan Society of Hepatology (JSH) decided to establish its own assessment criteria for sarcopenia in liver disease because the number of liver disease patients with sarcopenia is expected to increase and there is cumulative evidence to indicate sarcopenic patients have poor clinical outcomes. A working group to create assessment criteria for sarcopenia has thus been established by the JSH. In this article, we summarize the current knowledge with regard to sarcopenia and present the assessment criteria for sarcopenia in liver disease proposed by the JSH (1st edition). To the best of our knowledge, this is globally the first proposed assessment criteria for sarcopenia specializing in liver disease.
机译:Sarcopenia由肌肉损失和肌肉功能障碍定义。基于原因,SARCOPENIA分为初级和中学类型。原发性SARCOPENIA主要是衰老相关的SARCEPENIA,而继发性SARCOPENIA是伴随潜在疾病的肌肉质量和力量降低。鉴于肝脏在新陈代谢中的基本作用,肝病患有营养障碍或其他因素导致的继发性SARCEPENIA可能经常发生。 2015年,日本肝脏学会(JSH)决定为肝病的SARCOPENIA制定自己的评估标准,因为患有嗜睡症的肝病患者的数量预计会增加,并且存在累积证据表明患者患者临床结果不佳。因此,JSH建立了一个为康斯科西亚创造评估标准的工作组。在本文中,我们总结了目前关于SARCOPENIA的知识,并提出了JSH(第1版)提出的肝病中SARCOPENIA的评估标准。据我们所知,这是全球性的第一个专门从事肝病的康迟病毒评估标准。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号